An edition of Marketing of Clozaril (1991)

Marketing of Clozaril

improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.

by

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Cover of: Marketing of Clozaril by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights.
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today
Notes
  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Notes

Check nearby libraries

Buy this book

Last edited by MARC Bot
November 14, 2020 | History
Edit
An edition of Marketing of Clozaril (1991)

Marketing of Clozaril

improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.

by

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

This edition doesn't have a description yet. Can you add one?

Publish Date
Publisher
U.S. G.P.O., For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Language
English
Pages
139

Check nearby libraries

Buy this book

Subjects
Clozapine, Cost control, Drugs, Marketing, Medical care, Prices, Sandoz Pharmaceuticals Corporation, Drug accessibility, Whistle blowing, United States, United States. Federal Grain Inspection Service
Places
United States

Showing 1 featured edition. View all 1 editions?

Edition Availability
Cover of: Marketing of Clozaril
Marketing of Clozaril: improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.
1991, U.S. G.P.O., For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
in English
  • Not in Library
Libraries near you: WorldCat

Add another edition?

Book Details

Edition Notes

Includes bibliographical references.
"Serial no. J-102-6."

Published in
Washington
Series
S. hrg. ;, 102-175

Classifications

Dewey Decimal Class
363.19/4
Library of Congress
KF26 .J835 1991, KF26 .A35 1990a

The Physical Object

Pagination
iii, 139 p. ;
Number of pages
139

ID Numbers

Open Library
OL1667198M
ISBN 10
0160354927
LCCN
91601788, 91601811
Goodreads
4046314

Source records

Scriblio MARC record
Library of Congress MARC record
Library of Congress MARC record
Library of Congress MARC record

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
November 14, 2020 Edited by MARC Bot import existing book
November 14, 2020 Edited by MARC Bot import existing book
December 4, 2010 Edited by Open Library Bot Added subjects from MARC records.
April 28, 2010 Edited by Open Library Bot Linked existing covers to the work.
December 9, 2009 Created by WorkBot add works page